Clinical Trials Logo

Filter by:
NCT ID: NCT03205137 Withdrawn - Hypertension Clinical Trials

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Start date: June 1, 2022
Phase:
Study type: Observational

The primary objective of this study is to compare the medication adherence measured by PDC of patients with FDC or double-pill combination therapy in real-world Japanese therapeutic practice.The further objective of this study is how much influence the background of patients to the adherence.

NCT ID: NCT02895815 Withdrawn - Clinical trials for Macular Degeneration

Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)

Start date: April 9, 2018
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the efficacy and safety of CNTO 2476 cells administered into the subretinal space by the suprachoroidal surgical approach and the subretinal access kit (SRAK-02) in participants with visual acuity impairment associated with Geographic Atrophy (GA) secondary to Age Related Macular Degeneration (AMD).

NCT ID: NCT02783547 Withdrawn - Clinical trials for Myelodysplastic Syndrome

Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome

Start date: December 2015
Phase: Phase 1
Study type: Interventional

This is a Phase 1 clinical trial to evaluate the tolerability of a combination therapy of SyB C-1101 (rigosertib sodium) and Azacytidine and to determine the recommended dose of SyB C-1101for Phase 2 trial in patients with myelodysplastic syndrome.

NCT ID: NCT02713061 Withdrawn - Clinical trials for Influenza Prevention

A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants

Start date: March 2016
Phase: Phase 2
Study type: Interventional

This clinical trial is a Phase 2 study of a single subcutaneous injection of TAK-850 for 22 days in healthy Japanese adults.

NCT ID: NCT02426021 Withdrawn - Clinical trials for Healthy Japanese and Caucasian Male Adults

Phase 1 Single Subcutaneous Dose Study of MLN1202

Start date: April 2015
Phase: Phase 1
Study type: Interventional

The objective of the study is to investigate the safety, pharmacokinetics, and pharmacodynamic effect of a single dose of MLN1202 in healthy Japanese male adults.

NCT ID: NCT02400775 Withdrawn - Clinical trials for Essential Hypertension With Stable Angina and Dyslipidemia

A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.

ALIVE
Start date: March 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effects of oral azilsartan once daily for 32 weeks on coronary artery plaque in essential hypertensive patients with stable angina and dyslipidemia.

NCT ID: NCT02330861 Withdrawn - Coronary Stenosis Clinical Trials

Relationship Between Pressure and Flow Velocity on Coronary Physiology

Start date: December 2014
Phase: N/A
Study type: Interventional

Subjects are patients who are planned to do percutaneous coronary intervention for coronary stenosis in the left circumflex artery without other stenosis in the left ascending artery and the right coronary artery, or a patient with normal coronary artery. Immediately after coronary angiography or percutaneous coronary intervention, the investigators will evaluate for coronary hemodynamics by distribution of wave intensity which is calcurated by coronary pressure and flow velocity with Combowire in each coronary segment. Also, they will assess coronary morphology by View It in each coronary segment.

NCT ID: NCT02322606 Withdrawn - Clinical trials for Healthy Japanese Adult Male

A Phase 1, Single and Multiple Dose Study of TAK-137

Start date: November 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of TAK-137 in healthy male subjects.

NCT ID: NCT02290626 Withdrawn - Clinical trials for Gastro-oesophageal Reflux

Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation

Start date: November 2014
Phase: N/A
Study type: Interventional

Study 1: A randomized, crossover trial using elemental or semi-solid diets containing contrast medium as a tracer given to bedridden PEG patients. The distribution of the administered diets is assessed at the distal esophagus, proximal and distal stomach using a plain CT before and 1 hour after the administration. Study 2: A randomized, crossover trial using elemental or semi-solid diets containing 13C sodium acetate as a tracer given to bedridden PEG patients. 13C breath tests are performed to estimate gastric emptying.

NCT ID: NCT02174575 Withdrawn - Clinical trials for Hepatocellular Carcinoma

Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery

Start date: July 2014
Phase: Phase 4
Study type: Interventional

- It has been shown that patients who undergo liver resection surgery are at high risk for postoperative acute kidney injury (AKI). - Sevoflurane may increase the risk for postoperative AKI because of production of compound-A. - Therefore, we have planned to investigate the effects of different anesthetic agents on postoperative renal function. - Patients undergoing liver resection surgery are randomized into 2 groups. - One of the groups receives sevoflurane and the other group receives desflurane. - Blood and urine specimen are sampled both pre- and postoperatively, and several biomarkers are compared between the groups.